Parya Saberi

Summary

Affiliation: University of California
Country: USA

Publications

  1. ncbi Ambiguity, ambivalence, and apprehensions of taking HIV-1 pre-exposure prophylaxis among male couples in San Francisco: a mixed methods study
    Parya Saberi
    University of California San Francisco, San Francisco, California, United States of America
    PLoS ONE 7:e50061. 2012
  2. ncbi Directly observed versus self-administered antiretroviral therapies: preference of HIV-positive jailed inmates in San Francisco
    Parya Saberi
    University of California, San Francisco, San Francisco, CA, USA
    J Urban Health 89:794-801. 2012
  3. ncbi Immunologic benefits of enfuvirtide in patients enrolled in a drug assistance program
    Parya Saberi
    Department of Family and Community Medicine, University of California at San Francisco, San Francisco, CA 94143, USA
    Ann Pharmacother 42:621-6. 2008
  4. ncbi Medication adherence: tailoring the analysis to the data
    Parya Saberi
    Department of Medicine, University of California, San Francisco, 94105, USA
    AIDS Behav 15:1447-53. 2011
  5. ncbi Quality of sleep: associations with antiretroviral nonadherence
    Parya Saberi
    Center for AIDS Prevention Studies, University of California San Francisco, USA
    AIDS Patient Care STDS 25:517-24. 2011
  6. ncbi Clinical implications of the nelfinavir-proton pump inhibitor drug interaction in patients with human immunodeficiency virus
    Parya Saberi
    Department of Medicine, University of California San Francisco, San Francisco, California 94105, USA
    Pharmacotherapy 31:253-61. 2011
  7. ncbi Pharmacy-refill measure of adherence to efavirenz can predict maintenance of HIV viral suppression
    P Saberi
    Department of Family and Community Medicine, University of California San Francisco, US
    AIDS Care 20:741-5. 2008
  8. ncbi Technology-based self-care methods of improving antiretroviral adherence: a systematic review
    Parya Saberi
    Department of Medicine, University of CaliforniaSan Francisco, San Francisco, California, United States of America
    PLoS ONE 6:e27533. 2011
  9. ncbi Improving adherence and clinical outcomes through an HIV pharmacist's interventions
    Angela Ma
    Department of Pharmacy, Kaiser Permanente Medical Care Program, Vallejo, CA, USA
    AIDS Care 22:1189-94. 2010
  10. ncbi Pharmacists as providers of HIV pre-exposure prophylaxis
    Christine Bruno
    Kaiser Permanente, Vallejo, CA, USA
    Int J Clin Pharm 34:803-6. 2012

Detail Information

Publications12

  1. ncbi Ambiguity, ambivalence, and apprehensions of taking HIV-1 pre-exposure prophylaxis among male couples in San Francisco: a mixed methods study
    Parya Saberi
    University of California San Francisco, San Francisco, California, United States of America
    PLoS ONE 7:e50061. 2012
    ....
  2. ncbi Directly observed versus self-administered antiretroviral therapies: preference of HIV-positive jailed inmates in San Francisco
    Parya Saberi
    University of California, San Francisco, San Francisco, CA, USA
    J Urban Health 89:794-801. 2012
    ..We surveyed the preference of 102 HIV-positive jailed inmates at the San Francisco City and County Jails regarding receiving ARVs via DOT versus g-SAT while incarcerated. Participants overwhelmingly preferred g-SAT over DOT...
  3. ncbi Immunologic benefits of enfuvirtide in patients enrolled in a drug assistance program
    Parya Saberi
    Department of Family and Community Medicine, University of California at San Francisco, San Francisco, CA 94143, USA
    Ann Pharmacother 42:621-6. 2008
    ..Randomized clinical trials have demonstrated that enfuvirtide plus an optimized background regimen can cause a significant increase in CD4+ cell counts and a reduction in HIV RNA levels...
  4. ncbi Medication adherence: tailoring the analysis to the data
    Parya Saberi
    Department of Medicine, University of California, San Francisco, 94105, USA
    AIDS Behav 15:1447-53. 2011
    ..Use of the hurdle and ZINB models are powerful and valuable approaches in analyzing adherence data which yield a more complete picture than LR alone. We recommend adoption of this methodology for future antiretroviral adherence research...
  5. ncbi Quality of sleep: associations with antiretroviral nonadherence
    Parya Saberi
    Center for AIDS Prevention Studies, University of California San Francisco, USA
    AIDS Patient Care STDS 25:517-24. 2011
    ..Recognition and timely treatment of sleep difficulties may result in reduced ARV nonadherence with beneficial clinical and public health implications...
  6. ncbi Clinical implications of the nelfinavir-proton pump inhibitor drug interaction in patients with human immunodeficiency virus
    Parya Saberi
    Department of Medicine, University of California San Francisco, San Francisco, California 94105, USA
    Pharmacotherapy 31:253-61. 2011
    ..To determine if the concomitant use of nelfinavir and proton pump inhibitors (PPIs) in patients with human immunodeficiency virus (HIV) infection results in the loss of virologic control...
  7. ncbi Pharmacy-refill measure of adherence to efavirenz can predict maintenance of HIV viral suppression
    P Saberi
    Department of Family and Community Medicine, University of California San Francisco, US
    AIDS Care 20:741-5. 2008
    ..In conclusion, lower adherence rates (<95%) on an efavirenz-based regimen were more successful in maintaining viral suppression than previously found with unboosted protease inhibitor-based regimens...
  8. ncbi Technology-based self-care methods of improving antiretroviral adherence: a systematic review
    Parya Saberi
    Department of Medicine, University of CaliforniaSan Francisco, San Francisco, California, United States of America
    PLoS ONE 6:e27533. 2011
    ..Self-care refers to activities that patients undertake to maintain and improve health, such as strategies to achieve and maintain high levels of antiretroviral adherence...
  9. ncbi Improving adherence and clinical outcomes through an HIV pharmacist's interventions
    Angela Ma
    Department of Pharmacy, Kaiser Permanente Medical Care Program, Vallejo, CA, USA
    AIDS Care 22:1189-94. 2010
    ..001). In conclusion, HIV clinical pharmacists may play an important role in reducing pill burden and dosing frequency, increasing medication adherence, and improving clinical outcomes...
  10. ncbi Pharmacists as providers of HIV pre-exposure prophylaxis
    Christine Bruno
    Kaiser Permanente, Vallejo, CA, USA
    Int J Clin Pharm 34:803-6. 2012
    ..Here we discuss reasons favoring the establishment of a protocol-based, pharmacist-run PrEP clinic...
  11. ncbi The impact of HIV clinical pharmacists on HIV treatment outcomes: a systematic review
    Parya Saberi
    Department of Medicine, University of California, San Francisco, CA, USA
    Patient Prefer Adherence 6:297-322. 2012
    ..In a HIV multidisciplinary care team, the HIV pharmacist is well-equipped to provide this expertise. We conducted a systematic review to assess the impact of HIV pharmacists on HIV clinical outcomes...
  12. ncbi Preliminary support for the construct of health care empowerment in the context of treatment for human immunodeficiency virus
    Mallory O Johnson
    Department of Medicine, University of California, San Francisco, CA, USA
    Patient Prefer Adherence 6:395-404. 2012
    ..Using data from two ongoing trials of social and behavioral aspects of HIV treatment, we examined preliminary support for hypothesized clinical outcomes and antecedents of HCE in the context of HIV treatment...